UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.15 +0.16 (+0.20%) GOLD FUTURES
2,316.80 -5.50 (-0.24%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,042.46 -1,271.63 (-2.53%)
Medeon Biodesign, Inc. (6499.TWO)
Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
At close: 01:30PM CST
Currency in TWD
Valuation measures4
| Market cap (intra-day) | 3.94B |
| Enterprise value | 2.20B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 23.01 |
| Price/book (mrq) | 1.85 |
| Enterprise value/revenue | 12.40 |
| Enterprise value/EBITDA | -1.99 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.70 |
| 52-week change 3 | -25.75% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 57.91 |
| 52-week low 3 | 39.45 |
| 50-day moving average 3 | 42.96 |
| 200-day moving average 3 | 46.91 |
Share statistics
| Avg vol (3-month) 3 | 101.96k |
| Avg vol (10-day) 3 | 34.2k |
| Shares outstanding 5 | 91.84M |
| Implied shares outstanding 6 | 94.66M |
| Float 8 | 48.38M |
| % held by insiders 1 | 50.69% |
| % held by institutions 1 | 4.15% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.5 |
| Forward annual dividend yield 4 | 1.18% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 23 Aug 2023 |
| Last split factor 2 | 1049.9929:1000 |
| Last split date 3 | 23 Aug 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -389.99% |
Management effectiveness
| Return on assets (ttm) | -15.46% |
| Return on equity (ttm) | -42.09% |
Income statement
| Revenue (ttm) | 196.26M |
| Revenue per share (ttm) | 2.13 |
| Quarterly revenue growth (yoy) | 50.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -797.3M |
| Net income avi to common (ttm) | -1.2B |
| Diluted EPS (ttm) | -12.87 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.14B |
| Total cash per share (mrq) | 23.27 |
| Total debt (mrq) | 186.74M |
| Total debt/equity (mrq) | 7.87% |
| Current ratio (mrq) | 10.05 |
| Book value per share (mrq) | 25.21 |
Cash flow statement
| Operating cash flow (ttm) | -755.08M |
| Levered free cash flow (ttm) | -455.87M |
© 2024 Yahoo. All rights reserved.